These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31051113)

  • 1. COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
    Labelle-Dumais C; Schuitema V; Hayashi G; Hoff K; Gong W; Dao DQ; Ullian EM; Oishi P; Margeta M; Gould DB
    Am J Hum Genet; 2019 May; 104(5):847-860. PubMed ID: 31051113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations.
    Kuo DS; Labelle-Dumais C; Mao M; Jeanne M; Kauffman WB; Allen J; Favor J; Gould DB
    Hum Mol Genet; 2014 Apr; 23(7):1709-22. PubMed ID: 24203695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sodium 4-phenylbutyrate to define therapeutic parameters for reducing intracerebral hemorrhage and myopathy in
    Hayashi G; Labelle-Dumais C; Gould DB
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29895609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
    Jeanne M; Jorgensen J; Gould DB
    Circulation; 2015 May; 131(18):1555-65. PubMed ID: 25753534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila basement membrane collagen col4a1 mutations cause severe myopathy.
    Kelemen-Valkony I; Kiss M; Csiha J; Kiss A; Bircher U; Szidonya J; Maróy P; Juhász G; Komonyi O; Csiszár K; Mink M
    Matrix Biol; 2012 Jan; 31(1):29-37. PubMed ID: 22037604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke.
    Jeanne M; Labelle-Dumais C; Jorgensen J; Kauffman WB; Mancini GM; Favor J; Valant V; Greenberg SM; Rosand J; Gould DB
    Am J Hum Genet; 2012 Jan; 90(1):91-101. PubMed ID: 22209247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome.
    Mao M; Popli T; Jeanne M; Hoff K; Sen S; Gould DB
    Dis Model Mech; 2021 Apr; 14(4):. PubMed ID: 34424299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.
    Jeanne M; Gould DB
    Matrix Biol; 2017 Jan; 57-58():29-44. PubMed ID: 27794444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.
    Kuo DS; Labelle-Dumais C; Gould DB
    Hum Mol Genet; 2012 Oct; 21(R1):R97-110. PubMed ID: 22914737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling.
    Labelle-Dumais C; Mazur C; Kaya S; Obata Y; Lee B; Acevedo C; Alliston T; Gould DB
    Matrix Biol; 2024 Nov; 133():1-13. PubMed ID: 39097038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated TGFβ signaling contributes to cerebral small vessel disease in mouse models of Gould syndrome.
    Branyan K; Labelle-Dumais C; Wang X; Hayashi G; Lee B; Peltz Z; Gorman S; Li BQ; Mao M; Gould DB
    Matrix Biol; 2023 Jan; 115():48-70. PubMed ID: 36435425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.
    Meuwissen ME; Halley DJ; Smit LS; Lequin MH; Cobben JM; de Coo R; van Harssel J; Sallevelt S; Woldringh G; van der Knaap MS; de Vries LS; Mancini GM
    Genet Med; 2015 Nov; 17(11):843-53. PubMed ID: 25719457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic COLGALT1 variants are associated with cerebral small vessel disease.
    Miyatake S; Schneeberger S; Koyama N; Yokochi K; Ohmura K; Shiina M; Mori H; Koshimizu E; Imagawa E; Uchiyama Y; Mitsuhashi S; Frith MC; Fujita A; Satoh M; Taguri M; Tomono Y; Takahashi K; Doi H; Takeuchi H; Nakashima M; Mizuguchi T; Takata A; Miyake N; Saitsu H; Tanaka F; Ogata K; Hennet T; Matsumoto N
    Ann Neurol; 2018 Dec; 84(6):843-853. PubMed ID: 30412317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated TGFβ signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice.
    Mao M; Labelle-Dumais C; Tufa SF; Keene DR; Gould DB
    Matrix Biol; 2022 Jun; 110():151-173. PubMed ID: 35525525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles.
    Favor J; Gloeckner CJ; Janik D; Klempt M; Neuhäuser-Klaus A; Pretsch W; Schmahl W; Quintanilla-Fend L
    Genetics; 2007 Feb; 175(2):725-36. PubMed ID: 17179069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)?
    Zhang KW; Tonna S; Wang YY; Rana K; Padavarat S; Savige J
    Pediatr Nephrol; 2007 May; 22(5):645-51. PubMed ID: 17216253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Col4a1 mutations cause progressive retinal neovascular defects and retinopathy.
    Alavi MV; Mao M; Pawlikowski BT; Kvezereli M; Duncan JL; Libby RT; John SW; Gould DB
    Sci Rep; 2016 Jan; 6():18602. PubMed ID: 26813606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HANAC Col4a1 Mutation in Mice Leads to Skeletal Muscle Alterations due to a Primary Vascular Defect.
    Guiraud S; Migeon T; Ferry A; Chen Z; Ouchelouche S; Verpont MC; Sado Y; Allamand V; Ronco P; Plaisier E
    Am J Pathol; 2017 Mar; 187(3):505-516. PubMed ID: 28056338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humans.
    Labelle-Dumais C; Dilworth DJ; Harrington EP; de Leau M; Lyons D; Kabaeva Z; Manzini MC; Dobyns WB; Walsh CA; Michele DE; Gould DB
    PLoS Genet; 2011 May; 7(5):e1002062. PubMed ID: 21625620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy.
    Gunda B; Mine M; Kovács T; Hornyák C; Bereczki D; Várallyay G; Rudas G; Audrezet MP; Tournier-Lasserve E
    J Neurol; 2014 Mar; 261(3):500-3. PubMed ID: 24390199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.